CI Platform
Sign in
Pharmosa Biopharm Inc.6875Unknown exchange
Current ReportFundamental Reports

Asia / TAIWAN

Report Sections1

Available for this company

Reporting UnitBillions

Unknown exchange

Company Overview

Pharmosa Biopharm, Inc. operates as a biotechnology company, which engages in the research, development, and sale of innovative drugs and medical equipment. Its products include metered dose inhalers, soft mist inhalers, and liquid nebulizers. The company was founded on May 25, 2000 and is headquartered in Taipei, Taiwan.

Pharmosa Biopharm, Inc. operates as a biotechnology company, which engages in the research, development, and sale of innovative drugs and medical equipment. Its products include metered dose inhalers, soft mist inhalers, and liquid nebulizers. The company was founded on May 25, 2000 and is headquartered in Taipei, Taiwan.

Includes quarterly earnings and dividends.

Company Details

Major IndustryPharmaceuticals & Biotechnology
Sub IndustryBiological Products Exc. Diagnostic
CountryTAIWAN
Employees35
Reporting UnitBillions
Primary ExchangeUnknown exchange
Instrument TypeEquity
Websitehttp://www.pharmosa.com.tw
Wright IDC158T0JNW

Key Metrics

Current price$27.10
Market cap$3.50 B
P/E ration/a
52-week perf.-47.4%
Common shares129.2 M
Share typeGu
Quality ratingDBD0
Dividend yield0.00%

Recent stock performance

1 Week0.0%
4 Week-9.4%
13 Week-18.3%

Officers

ChairmanJerry Wang

Address

No66 Sanchong Road Nangang District

TAIPEI

TAIWAN

115

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.